Eagle Genomics’ AI augmented knowledge discovery platform is revolutionising how scientists conduct life sciences research and is bridging the gap between data and new insights in a rapid, systematic and traceable way. It puts data science at the fingertips of biologists to drastically reduce time and cost of research, Eagle is enabling customers in the fields of food, agriculture, personal care and more to achieve radical productivity improvements and true data-driven discovery.
CEO, Eagle Genomics
"I have known the partners at ETF for many years and have been impressed with their work and with the portfolio that they have built. Through my career as an entrepreneur I have been very keen to work with them and as the leading sustainability orientated investor I am delighted to now have ETF as a shareholder. Eagle Genomics is addressing a grand challenge with sustainability at its root and I know that the unique expertise and engagement that ETF will bring will be a tremendous asset as we scale the business."